Research theme for competitive and other funds (2):
2019 - 2021 Comprehensive Analysis of Molecular Characteristics of Extramammary Pagets disease
2016 - 2019 T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non-Small Cell Lung Cancer
Papers (34):
Kana Fujimoto, Satomi Watanabe, Yuto Yasuda, Emi Date, Yasuhiro Kawabata, Hiroaki Kanemura, Takayuki Takahama, Kimio Yonesaka, Norishige Iizuka, Ken-Ichi Takahashi, et al. Successful treatment with atezolizumab combination chemotherapy in a patient with high-grade fetal adenocarcinoma of the lung: A case report. Thoracic cancer. 2023. 14. 2. 214-217
Toshio Shimizu, Kazuhiko Nakagawa, Hidetoshi Hayashi, Tsutomu Iwasa, Hisato Kawakami, Satomi Watanabe, Noboru Yamamoto, Kan Yonemori, Takafumi Koyama, Jun Sato, et al. Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 study. Investigational new drugs. 2022. 41. 1. 1-12
Kohsuke Isomoto, Koji Haratani, Satomi Watanabe, Masayuki Takeda, Tsutomu Iwasa, Kazuhiko Nakagawa. Successful treatment of a case of hormone receptor-positive metastatic extramammary Paget disease with tamoxifen. Investigational new drugs. 2022. 40. 1. 194-197
2014 - 2018 Kindai University Graduate School of Medical Sciences
2006 - 2012 Osaka city university
Professional career (2):
MD (大阪市立大学)
PhD (近畿大学)
Association Membership(s) (6):
American Society of Clinical Oncology
, European Society of Medical Oncology
, Japanese Society of Medical Oncology
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE
, The Japan Lung Cancer Society
, Japanese Breast Cancer Society